Library
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man.
6 October 2020. doid: 10.1111/bcp.14588
Saghari M, Gal P, Ziagkos D, Burggraaf J, Powell JF, Brennan N, Rissmann R, van Doorn MBA, Moerland M
View publicationKeyhole limpet haemocyanin (KLH) immunization is a clinical model for the evaluation of human antibody responses. The current study evaluated the anti-KLH antibody response after KLH immunization and the delayed-type hypersensitivity (DTH) response following intradermal KLH administration, using objective imaging techniques.
Advancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
